Global Generic Injectables Market Analysis & Forecast 2017-2022 - ResearchAndMarkets.com

DUBLIN--()--The "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to ResearchAndMarkets.com's offering.

The global generic injectables market reached a value of more than US$ 43 Billion in 2016, exhibiting a CAGR of around 9% during 2009-2016.

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D cycle is cheaper and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments.

The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the total market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share.

On a regional basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the total global share.

Companies Mentioned

  • Baxter
  • Fresenius Kabi
  • Hikma
  • Hospira (Pfizer)
  • Sagent
  • Sandoz (Novartis)
  • Sanofi

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Generic Drug Market

6 Global Generic Drug Delivery Market

7 Global Generic Injectables Market

8 Global Generic Injectables Market: Performance of Key Regions

9 Market by Therapeutic Area

10 Market by Distribution Channel

11 Global Generic Injectable Market: Competitive Landscape

12 Generic Injectable Manufacturing Process

13 Project Details, Requirements and Costs Involved

14 Loans and Financial Assistance

15 Project Economics

16 Key Player Profiles

For more information about this report visit https://www.researchandmarkets.com/research/ql3mcx/global_generic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables